Abstract
The development of antimalarial drug resistance has led to increasing calls for the introduction of artemisinin-based combination therapy (ACT). However, little evidence is available on the full costs associated with changing national malaria treatment policy. This paper presents findings on the actual drug and non-drug costs associated with deploying ACT in one district in Tanzania, and uses these data to estimate the nationwide costs of implementation in a setting where identification of malaria cases is primarily dependant on clinical diagnosis. Detailed data were collected over a three year period on the financial costs of providing ACT in Rufiji District as part of a large scale effectiveness evaluation, including costs of drugs, distribution, training, treatment guidelines and other information, education and communication (IEC) materials and publicity. The district-level costs were scaled up to estimate the costs of nationwide implementation, using four scenarios to extrapolate variable costs. The total district costs of implementing ACT over the three year period were slightly over one million USD, with drug purchases accounting for 72.8% of this total. The composite (best) estimate of nationwide costs for the first thr...Continue Reading
References
Aug 7, 1999·Lancet·C A GoodmanA J Mills
Sep 24, 1999·Annals of Tropical Medicine and Parasitology·P B Bloland, M Ettling
Sep 24, 1999·Transactions of the Royal Society of Tropical Medicine and Hygiene·A H KilianG Kabagambe
Oct 6, 1999·Lancet·L B Lerer
Jun 27, 2001·The American Journal of Tropical Medicine and Hygiene·J G Breman
Nov 13, 2001·Tropical Medicine & International Health : TM & IH·UNKNOWN East African Network for Monitoring Antimalarial Treatment (EANMAT)
Nov 13, 2001·Tropical Medicine & International Health : TM & IH·P OlliaroJ Rigal
May 2, 2002·BMC International Health and Human Rights·Fidel FontPedro Alonso
Aug 7, 2003·Trends in Parasitology·Robert W SnowAwash Teklehaimanot
Apr 14, 2004·Tropical Medicine & International Health : TM & IH·V M MarshK Marsh
Sep 14, 2004·Tropical Medicine & International Health : TM & IH·Charlotte MuhekiKaren I Barnes
Aug 16, 2005·Acta Tropica·T K Mutabingwa
Sep 2, 2005·Tropical Medicine & International Health : TM & IH·P AgnameyP Olliaro
Jan 21, 2006·Malaria Journal·Hugh ReyburnChris Drakeley
Mar 24, 2006·Tropical Medicine & International Health : TM & IH·J-A MulliganA Mills
Jul 8, 2011·The American Journal of Tropical Medicine and Hygiene·Virginie MenemedengueRachida Tahar
Citations
Apr 20, 2012·Malaria Journal·Bernadette J HuhoSalim Mk Abdulla
Jul 13, 2013·Malaria Journal·Joseph D NjauS Patrick Kachur
Nov 15, 2013·Malaria Journal·Asia MohammedReginald A Kavishe
Dec 24, 2008·Malaria Journal·Elizabeth A JumaBernhards R Ogutu
Jul 21, 2009·Malaria Journal·West SuhanicPeter Pennefather
Nov 4, 2009·Cost Effectiveness and Resource Allocation : C/E·Nisso KasymovaBenusrat Sharipova
Jan 18, 2013·Parasites & Vectors·Jephtha C NmorNoboru Minakawa
Jan 6, 2011·PloS One·James BuchananNicholas White
Apr 23, 2014·Malaria Journal·Sungwa I MatondoReginald A Kavishe
Mar 6, 2013·The American Journal of Tropical Medicine and Hygiene·Fabian M MashauriLeonard E G Mboera
Jan 14, 2011·Tropical Medicine & International Health : TM & IH·J I ThwingS P Kachur
Dec 15, 2015·Malaria Research and Treatment·Karen N ZablonZanda Bochkaeva
Jun 8, 2015·BMC Public Health·Stephen M KibusiCourtney S Hines
Sep 3, 2009·PloS One·Oliver J SabotCatherine Goodman
Jun 25, 2016·Malaria Journal·Reginald A KavisheMichael Alifrangis
Jul 11, 2014·Malaria Journal·Reginald A KavisheMichael Alifrangis
Jan 1, 2014·The Review of Economic Studies·Achyuta Adhvaryu
Apr 21, 2020·Parasites & Vectors·Serkadis DebalkeLuc Duchateau
May 1, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Lais Pessanha de CarvalhoJana Held
Jun 2, 2021·PLoS Medicine·Angela DevineYoel Lubell